share_log

Allogene Therapeutics | 3: Initial statement of beneficial ownership of securities-CHIEF FINANCIAL OFFICER Parker Geoffrey M.

SEC announcement ·  Oct 16, 2023 19:25
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more